Do I Qualify?

Make an Appointment

Content Hub

Resources

Find a Dispensary Read Articles

Back

Let us be your cannabis companion. Explore lifestyle hacks, how-to guides, and the latest in cannabis news.

Blog

See all the latest news about Cannabis

Conditions

The impact of cannabis on various conditions

Cannabis 101

Glossary of basic cannabis terminology

Applying for your medical marijuana card is easier than ever. Just book an appointment. Talk to a doctor. And get your card. Bing. Bam. Boom.

Marijuana Doctors

Get your medical marijuana card

Cannabis Consultation

One on one with a cannabis coach

Patient Login

Sign in to your Veriheal patient account

Your medical cannabis journey simplified: find partnered dispensaries, explore pricing options, earn rewards, and get answers to FAQs, all in one spot.

About

Learn more about who Veriheal is

Pricing

Learn more about our flexible patment options

Contact Us

Get in touch with any questions you have

Edible dosage Cacluator

Get dosage info right at your fingertips

x
Politics

Why the FDA Won’t Regulate CBD

Anna Schwartz

by Anna Schwartz

March 15, 2023 08:30 am ET Estimated Read Time: 4 Minutes
Why the FDA Won’t Regulate CBD

In 2018, former President Donald Trump signed the Farm Bill into law. The Farm Bill is the federal government’s primary agricultural and food policy instrument. Every five years, Congress deals with renewing and revising the comprehensive bill. Before 2018, cannabis was not part of the conversation around farm subsidies or crop insurance. With the passing of the Farm Bill, hemp became federally legal.

All hemp is cannabis, but not all cannabis is hemp. When the 2018 Farm Bill legalized hemp, it defined hemp as cannabis containing less than 0.3% THC. This opened the door for other cannabinoids and derivatives, including cannabidiol (CBD), to enter the open market. 

CBD is the second-most abundant compound in cannabis and hemp after tetrahydrocannabinol (THC). While CBD is technically psychoactive, it does not cause intoxication like THC. The Farm Bill outlines that CBD sold to the public, not medical or recreational cannabis, must come from hemp. While there are over 80 different compounds found in cannabis, CBD has gained popularity for its treatment of anxiety and pain. Epidiolex is the first and only FDA-approved prescription CBD to treat seizures. 

The FDA and CBD

On Jan. 26 of this year, the FDA officially stated, “FDA Concludes that Existing Regulatory Frameworks for Foods and Supplements are Not Appropriate for Cannabidiol, Will Work with Congress on a New Way Forward.” Essentially, the FDA is taking a mostly hands-off approach regarding CBD products.

The Farm Bill will expire this year, so the question of whether CBD will be allowed in food or drinks will be negotiated by Congress in the newest version of the Farm Bill. Most CBD products that would be included in food or beverages fall under the category of dietary supplements.

Why You Should Get Your Medical Marijuana Card

Veriheal has satisfied millions of patients nationwide by giving them access to these benefits

  • Larger purchase limits
  • Peace of mind
  • Enhanced legal protection
  • Access to higher potency strains
  • Save up to 25% on cannabis purchases
  • Skip the line at the dispensary

The use of CBD in Epidiolex is largely why the FDA does not want involvement in regulating CBD products. A provision in the FDA’s Federal Food, Drug, and Cosmetic Act states that if a substance, such as THC or CBD, is an active ingredient in a drug that has been approved or is being investigated in clinical trials, those products containing that substance are excluded from the definition of a dietary supplement. Because it’s an ingredient in a drug, the FDA argues that CBD cannot be used in food and drinks. 

With negotiations of CBD being allowed in food or drinks, many other aspects of the Farm Bill must be examined. Other areas of concern are farm subsidies, food-stamp benefits, and many other topics.

During the January announcement, the FDA stated that there is not enough data addressing CBD’s “various safety concerns” to regulate marijuana-derived products as foods or supplements. FDA Deputy Commissioner Dr. Janet Woodcock referenced studies showing CBD can potentially harm the liver, interact with certain medications, and harm the male reproductive system. Studies also show concern about long-term use and exposure to children and pregnant people. 

The Growing CBD Market

CBD continues to grow in popularity and can be found in almost any type of product: food, makeup, and even dog foods. The United States has the largest population of use, with Europe having the second-most use. U.S. sales reached $4.17 billion in 2022, and forecasts predicted the market could quadruple by 2026. 

Research completed by Cross River Therapy reported that:

  • By 2024, the percentage of CBD users in the U.S. is expected to increase to 35%.
  • Of all U.S. citizens, 33% have tried CBD at least once.
  • 54% of U.S. citizens have some familiarity with CBD and other related CBD items made.
  • About 64 million people in the U.S. consumed CBD between 2018 and 2019.
  • Out of the people that used CBD, 22% claimed that it helped them reduce or entirely replace their over-the-counter and prescription medications. 

Other research shows that the U.S. hemp farmland increased from 25,713 acres in 2017 to 78,176 acres in 2018. In overall cannabis sales, Colorado tops the list, having sold over $1 billion since 2014. The other top sell states for CBD sales in 2019 are California ($730 million), Florida ($291 million), and New York ($215 million). Of the Americans who use CBD, the most common uses are for pain relief (64%), anxiety (49%), and insomnia (42%).

Post Your Comments

It's time to clear the smoke

Sign up for our newsletter

Get your medical marijuana card today
Sign up in under 5 minutes